Lv3
250 积分 2023-07-26 加入
Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
5天前
已完结
Deciding between one-step and two-step irreversible inhibition mechanisms on the basis of “ k obs ” data: A statistical approach
6天前
已完结
Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance
25天前
已完结
Ziritaxestat Drug–Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition
26天前
已完结
The Effect of Etoricoxib on the Pharmacokinetics of Oral Contraceptives in Healthy Participants
26天前
已完结
Drug–Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug–Drug Interaction Prediction
4个月前
已完结
Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models
4个月前
已完结
Multiple Substrate Binding by Cytochrome P450 3A4: Estimation of the Number of Bound Substrate Molecules
4个月前
已完结
Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process
5个月前
已完结
Irreversible Enzyme Inhibition Kinetics and Drug–Drug Interactions
5个月前
已关闭
皖公网安备34019202002308
